West Capital Expenditures from 2010 to 2025

WST Stock  USD 232.34  9.78  4.39%   
West Pharmaceutical Capital Expenditures yearly trend continues to be comparatively stable with very little volatility. Capital Expenditures is likely to outpace its year average in 2025. From the period from 2010 to 2025, West Pharmaceutical Capital Expenditures quarterly data regression had r-value of  0.88 and coefficient of variation of  57.98. View All Fundamentals
 
Capital Expenditures  
First Reported
1990-03-31
Previous Quarter
81.3 M
Current Value
104.9 M
Quarterly Volatility
23.3 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check West Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among West Pharmaceutical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 163.2 M, Total Revenue of 3 B or Gross Profit of 1 B, as well as many indicators such as Price To Sales Ratio of 8.68, Dividend Yield of 0.0023 or PTB Ratio of 9.36. West financial statements analysis is a perfect complement when working with West Pharmaceutical Valuation or Volatility modules.
  
Check out the analysis of West Pharmaceutical Correlation against competitors.

Latest West Pharmaceutical's Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of West Pharmaceutical Services over the last few years. Capital Expenditures are funds used by West Pharmaceutical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of West Pharmaceutical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is West Pharmaceutical's Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in West Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Slightly volatile
   Capital Expenditures   
       Timeline  

West Capital Expenditures Regression Statistics

Arithmetic Mean190,121,875
Geometric Mean160,893,176
Coefficient Of Variation57.98
Mean Deviation90,280,078
Median155,800,000
Standard Deviation110,241,594
Sample Variance12153.2T
Range361.6M
R-Value0.88
Mean Square Error3018.3T
R-Squared0.77
Slope20,295,074
Total Sum of Squares182298.1T

West Capital Expenditures History

2025395.9 M
2024377 M
2023362 M
2022284.6 M
2021253.4 M
2020174.4 M
2019126.4 M

About West Pharmaceutical Financial Statements

West Pharmaceutical shareholders use historical fundamental indicators, such as Capital Expenditures, to determine how well the company is positioned to perform in the future. Although West Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. The changes in West Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses on on West Pharmaceutical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Expenditures377 M395.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.